HLA Antibody Detection via Solid-Phase Antigen Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for transplant rejection screening, such as cell-based assays, fail to detect antibodies specific for denatured HLA antigens, which can lead to false positives and negatives, and do not account for the clinical significance of these antibodies in transplant rejection and graft vs. host disease, as they primarily focus on native HLA antigens.
Innovation Solution
Developing methods that utilize solid-phase substrates to selectively present and distinguish between native and denatured HLA antigens, allowing for the detection of antibodies specific to denatured HLA antigens, which involves preparing panels with both native and denatured HLA antigens and using techniques like low pH treatment to denature HLA antigens on substrates, enabling the separation and detection of these antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cell-based assays are used to screen for HLA antibodies, then the method is widely accepted and can detect antibodies against native HLA antigens, but it fails to detect antibodies specific for denatured HLA antigens leading to false positives and negatives
Solution Approach 1:
The assay system is segmented into two distinct parts: a first set of beads presenting native HLA antigens and a second set of beads presenting denatured HLA antigens. This segmentation allows simultaneous detection of both native and denatured antibodies, resolving the contradiction by making the assay versatile enough to detect both antibody types while maintaining measurement precision for each.
Solution Approach 2:
The invention creates a universal assay system that can detect both native and denatured HLA antibodies using a single combined methodology. By incorporating both native and denatured antigen-presenting beads into one assay protocol, the system achieves multi-functionality, eliminating the need for separate assays and improving both precision and versatility.
2Adaptability or versatility
If solid-phase substrates are used to present both native and denatured HLA antigens, then antibodies specific for denatured HLA antigens can be detected, but the device complexity increases
Solution Approach 1:
The invention uses bead-based copies of HLA antigens presented on solid-phase substrates. Instead of using complex cell-based systems, simplified bead copies presenting either native or denatured antigens are used. This copying approach maintains the ability to distinguish between antigen types while reducing device complexity by replacing complex biological systems with simplified artificial substrates.
Solution Approach 2:
The complex task of detecting both native and denatured antibodies is segmented into two separate bead sets, each specialized for one antigen type. This segmentation simplifies the overall system design by dividing the complex assay into manageable, specialized components, reducing device complexity while maintaining versatility.
3Ease of operation
If only native HLA antigens are screened, then the assay is simpler to perform, but it leads to false positives and negatives by not accounting for denatured HLA antibodies
Solution Approach 1:
The invention merges two previously separate screening approaches (native HLA antibody detection and denatured HLA antibody detection) into a single combined assay. By combining both native and denatured antigen presentations in one protocol, the method maintains ease of operation through a unified procedure while improving reliability by comprehensively detecting all relevant antibodies.
Solution Approach 2:
The combined assay system serves multiple functions simultaneously: detecting native antibodies, detecting denatured antibodies, and providing comprehensive transplant rejection prediction. This multi-functionality improves reliability without significantly complicating the procedure, as the expanded capabilities are integrated into a single universal assay platform.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the identification of antibodies reactive to denatured HLA antigens, which can predict transplant rejection and graft vs. host disease risks, improving the accuracy of HLA antibody and antigen profiling and reducing false results in transplant matching.
Implementation Method 1
contacting each panel with a serum sample and detecting binding of an antibody to the panel
Implementation Method 2
β2m can be dissociated from a HLA class I complex on a cell surface by acid treatment
Data Source
AI summary
The invention is directed to methods of screening for HLA antibodies comprising detecting antibodies specific for native HLA antigens and denatured HLA antigens. The invention also provides for method of predicting whether a transplant recipient has an increased risk for rejecting the transplanted organ.